Home vs Lab Sleep Apnea Testing for Sleep Apnea
(HATCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare home sleep apnea tests with traditional in-lab sleep studies for children with suspected sleep apnea, a condition where breathing stops and starts during sleep. Researchers seek to determine if home tests are as accurate, assist doctors in making treatment decisions, and provide more comfort for families. The trial includes two groups: one starts with the home test, the other with the lab test. Children ages 5-12 who are already scheduled for a sleep study at the Children's Hospital of Philadelphia may be suitable candidates. As an unphased trial, this study offers families the chance to contribute to research that could make sleep studies more accessible and comfortable for children.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that these sleep apnea testing methods are safe for children?
Research has shown that home sleep apnea tests (HSAT) are safe. These tests are already used to diagnose obstructive sleep apnea in adults. Many studies indicate that HSAT is as effective as traditional in-lab tests, especially for straightforward cases. The American Academy of Sleep Medicine recommends HSAT for certain patients.
HSAT is non-invasive, meaning it doesn't enter the body. It monitors breathing, heart rate, and oxygen levels during sleep. Most people find it comfortable due to its non-intrusive nature. There are no reports of major side effects or safety issues with HSAT. Its convenience and ease of use at home contribute to its popularity.
Overall, HSAT provides a safe and effective way to diagnose sleep apnea without requiring a hospital visit.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it's comparing home sleep apnea testing (HSAT) to the traditional in-lab sleep study, or polysomnography (PSG). The HSAT offers the convenience of testing in the comfort of your own home, which can be less intimidating and more accessible for patients. This method could make diagnosing sleep apnea easier and more affordable, potentially leading to earlier detection and treatment for more people. By comparing these two approaches, researchers hope to determine if the home test is as effective as the lab test, which could revolutionize how sleep apnea is diagnosed in the future.
What evidence suggests that this trial's methods could be effective for sleep apnea?
Research has shown that home sleep apnea tests (HSAT), one of the methods under study in this trial, can effectively identify obstructive sleep apnea (OSA). These tests allow people to easily monitor their breathing and oxygen levels at home, increasing accessibility. However, some studies suggest that HSAT might not fully capture the severity of sleep apnea because it doesn't track different sleep stages, which help measure total sleep time. Despite this limitation, HSAT remains a valuable tool for diagnosing OSA. This trial will compare HSAT with traditional in-lab polysomnography (PSG) to evaluate their effectiveness in diagnosing OSA.678910
Who Is on the Research Team?
Christopher Cielo, MD
Principal Investigator
Children's Hospital of Philadelphia
Are You a Good Fit for This Trial?
This trial is for children aged 5-12 who are being checked for sleep apnea at the Children's Hospital of Philadelphia. They need consent from a parent or guardian, and if old enough, their own agreement to participate. Kids living without parents, with breathing holes in their necks (tracheostomy), serious breathing problems during sleep, or recent sleep studies can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Testing
Participants are randomized to undergo either home sleep apnea testing (HSAT) or in-lab polysomnography (PSG) as the initial test
Alternate Testing
Participants complete the alternate test (HSAT or PSG) within one week of the initial test
Follow-up
Participants are monitored for safety and effectiveness after testing, and families complete questionnaires assessing acceptability and preference
What Are the Treatments Tested in This Trial?
Interventions
- Home sleep apnea test
- In-lab polysomnography
Home sleep apnea test is already approved in United States, European Union, Canada for the following indications:
- Diagnosis of obstructive sleep apnea (OSA)
- Monitoring of OSA treatment effectiveness
- Diagnosis of obstructive sleep apnea (OSA)
- Monitoring of OSA treatment effectiveness
- Diagnosis of obstructive sleep apnea (OSA)
- Monitoring of OSA treatment effectiveness
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor
University of Miami
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
National Institutes of Health (NIH)
Collaborator